CLIA Moderate Complexity Provision Should Provide Rapid HIV Test Access
This article was originally published in The Gray Sheet
Executive Summary
Expedited access to rapid HIV testing should be enabled under a special provision of the Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test category, FDA's Blood Products Advisory Committee concluded June 14.